Osteoprotegerin, Soluble Receptor Activator Nuclear Factor-κB Ligand, Nuclear Factor Kappa B and Intestinal Trefoil Factor 3 are Promising Biomarkers in Diagnosis and Follow- up - Egyptian Knowledge Bank

212851

Osteoprotegerin, Soluble Receptor Activator Nuclear Factor-κB Ligand, Nuclear Factor Kappa B and Intestinal Trefoil Factor 3 are Promising Biomarkers in Diagnosis and Follow- up

Article

Last updated: 24 Dec 2024

Overview Similar Items

Article

Serum Osteoprotegerin (OPG) as a Potential Biomarker for Disease Activity in Ulcerative Colitis

Article

OSTEOPROTEGERIN (OPG) AND SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND (S-RANKL) IN PATIENTS WITH RHEUMATOID ARTHRITIS

Article

Osteoprotegerin and Soluble TRAIL Serum Levels in Patients with Coronary Artery Disease

Article

Osteoprotegerin in Childhood Nephrotic Syndrome: Relation To Glucocorticoids, Parathyroid Hormone And Markers of Bone Metabolism

Article

OPG (Osteoprotegerin) as a biomarker of Coronary Artery Disease

Article

The Role of Soluble Subtype of the Receptor for Advanced Glycation End Product (sRAGE) in Rheumatoid Arthrirtis Disease Activity and Treatment Follow-up

Article

Pentraxin-3: A Novel Specific Biomarker for Inflammatory Bowel Disease Diagnosis

Article

N-terminal telopeptide (NTX) as a prognostic and predictive Marker of Bone Metastases in Breast Cancer patients after receiving bone supporting agents

Article

Interleukin-6 as a reliable biomarker for inflammatory bowel diseases

Article

Non Invasive Diagnosis to Predict Adynamic Bone Disease in Haemodialysed Patients